Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson’s Disease Severity
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background: Cognitive impairment (CI) is common in Parkinson’s disease (PD) and an important cause of disability. Screening facilitates early detection of CI and has implications for management. Preclinical disability is when patients have functional limitations but maintain independence through compensatory measures. Objective: The objective of this study was to investigate the relationship between scores on the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) with levels of PD severity and disability. Methods: PD patients (n = 2,234) in a large observational study were stratified by disease severity, based on Total Unified Parkinson’s Disease Rating Scale (Total UPDRS) and Hoehn and Yahr (HY) stage. Using MMSE (n = 1,184) or MoCA (n = 1,050) and basic (ADL) and instrumental activities of daily living (IADL) scales for disability, linear regression analysis examined associations between cognitive status and disability. Results: Cognition and disability were highly correlated, with the strongest correlation between IADL and MoCA. Only 16.0% of mean MMSE scores were below threshold for CI (28) and only in advanced PD (Total UPDRS 60+, HY≥3). MoCA scores fell below CI threshold (26) in 66.2% of the sample and earlier in disease (Total UPDRS 30+, HY≥2), corresponding with impairments in ADLs. Conclusion: In a large clinical dataset, a small fraction of MMSE scores fell below cutoff for CI, reinforcing that MMSE is an insensitive screening tool in PD. MoCA scores indicated CI earlier in disease and coincided with disability. This study shows that MoCA, but not MMSE is sensitive to the emergence of early cognitive impairment in PD and correlates with the concomitant onset of disability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Third, the limitations of the MMST were not considered during the study conceptualisation. Relevant evidence [62] suggests that this oversight may have limited our ability to detect the cognitive changes typically associated with PD, which relate to cognitive support needs and engagement with the intervention, particularly in home-based practice. This may have in turn affected participant eng”
From Comparing face-to-face and online LSVT®LOUD speech training using LSVT®Coach in patients with Parkinson’s disease: a pilot randomised controlled trial (2025) · cites this paper as [62]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107 · cited 1×
“Cognitive impairment is associated with more rapid progression of motor disability [39, 40] and advanced PD is associated with postural instability and falls [41], increased disability, and reduced quality of life [7–10].”
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams‐Gray, C. H., et al. (2012) · Movement Disorders · doi:10.1002/mds.24893 · Cited by 2,609
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M., & Morris, J. G. L. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,246
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
Hoops, S., Nazem, S., Siderowf, A. D., Duda, J. E., Xie, S. X., Stern, M. B., & Weintraub, D. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c34b47 · Cited by 1,260 · cited 2×
“Identifying CI informs management, impacts prognosis [5] and is a marker for disability in PD [6, 7].”
Dubois, B., Burn, D., Goetz, C., Aarsland, D., Brown, R. G., Broe, G. A., Dickson, D., Duyckaerts, C., Cummings, J., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21844 · Cited by 1,082 · cited 1×
“Several tools are available to screen for CI including the Mini-Mental State Examination (MMSE) [13, 14] and the Montreal Cognitive Assessment (MoCA) [15–17].”
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
Seppi, K., Ray Chaudhuri, K., Coelho, M., Fox, S. H., Katzenschlager, R., Perez Lloret, S., Weintraub, D., Sampaio, C., & and the collaborators of the Parkinson's Disease Update on Non‐Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence‐Based Medicine Committee (2019) · Movement Disorders · doi:10.1002/mds.27602 · Cited by 1,007
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams-Gray, C. H., Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 934 · cited 1×
“TheMMSEhasbeenreported tobeabetterpredictorofdementiaandtotrackbet-terwithPDprogression[20,34].”
The MoCA: Well-suited screen for cognitive impairment in Parkinson disease
Dalrymple-Alford, J. C., MacAskill, M. R., Nakas, C. T., Livingston, L., Graham, C., Crucian, G. P., Melzer, T. R., Kirwan, J., Keenan, R., Wells, S., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fc29c9 · Cited by 932 · cited 3×
“This is based on studies showing good discrimination between normal cognition and cognitive impairment at an optimal screening score of 26, with 90% sensitivity and 75% specificity [28].”
Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample
Rossetti, H. C., Lacritz, L. H., Cullum, C. M., & Weiner, M. F. (2011) · Neurology · doi:10.1212/wnl.0b013e318230208a · Cited by 801 · cited 1×
“While some studies suggest this cutoff may be too sensitive [30, 31], these studies were performed in community-based samples that spanned typical aging and neurodegenerative diseases thus had more varied educational backgrounds and cognitive impairment profiles compared to that of this PD cohort.”
Luis, C. A., Keegan, A. P., & Mullan, M. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2101 · Cited by 511 · cited 1×
“While some studies suggest this cutoff may be too sensitive [30, 31], these studies were performed in community-based samples that spanned typical aging and neurodegenerative diseases thus had more varied educational backgrounds and cognitive impairment profiles compared to that of this PD cohort.”
Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD Study
Yarnall, A. J., Breen, D. P., Duncan, G. W., Khoo, T. K., Coleman, S. Y., Firbank, M. J., Nombela, C., Winder-Rhodes, S., Evans, J. R., Rowe, J. B., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000066 · Cited by 422
Gill, D. J., Freshman, A., Blender, J. A., & Ravina, B. (2008) · Movement Disorders · doi:10.1002/mds.22017 · Cited by 390 · cited 1×
“We selected a cut-off of below 26 for the MoCA [6, 15, 16, 19, 21, 27–29].”
Effect of Psychiatric and Other Nonmotor Symptoms on Disability in Parkinson's Disease
Weintraub, D., Moberg, P. J., Duda, J. E., Katz, I. R., & Stern, M. B. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52219.x · Cited by 381 · cited 1×
“The presence of CI also has implications for quality of life for both the patient and caregiver and is associated with increased caregiver burden [8–12].”
Zadikoff, C., Fox, S. H., Tang‐Wai, D. F., Thomsen, T., de Bie, R. M. A., Wadia, P., Miyasaki, J., Duff‐Canning, S., Lang, A. E., & Marras, C. (2008) · Movement Disorders · doi:10.1002/mds.21837 · Cited by 339
Nazem, S., Siderowf, A. D., Duda, J. E., Ten Have, T., Colcher, A., Horn, S. S., Moberg, P. J., Wilkinson, J. R., Hurtig, H. I., Stern, M. B., et al. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.02096.x · Cited by 304
The evolution of disability in Parkinson disease
Shulman, L. M., Gruber‐Baldini, A. L., Anderson, K. E., Vaughan, C. G., Reich, S. G., Fishman, P. S., & Weiner, W. J. (2008) · Movement Disorders · doi:10.1002/mds.21879 · Cited by 292 · cited 4×
“We previously reported that loss of independence in ADLs (emerging between Total UPDRS 30 to 40 and HY 2 to 3), corresponds to the onset of gait and balance impairment [33].”
InfluentialSelf-citationGlobal scales for cognitive screening in Parkinson's disease: Critique and recommendations
Skorvanek, M., Goldman, J. G., Jahanshahi, M., Marras, C., Rektorova, I., Schmand, B., van Duijn, E., Goetz, C. G., Weintraub, D., Stebbins, G. T., et al. (2018) · Movement Disorders · doi:10.1002/mds.27233 · Cited by 229 · cited 2×
“While neuropsychological testing is the gold standard for diagnosing CI in PD, cognitive screening instruments are routinely used in clinical settings to detect cognitive impairment and to measure global cognitive function [3].”
Mamikonyan, E., Moberg, P. J., Siderowf, A., Duda, J. E., Have, T. T., Hurtig, H. I., Stern, M. B., & Weintraub, D. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.006 · Cited by 192 · cited 2×
“The MMSE is limited by insensitivity to executive dysfunction [18] and ceiling effect in PD [19, 20].”
Cognitive impairment in Parkinson's disease: Tools for diagnosis and assessment
Kulisevsky, J., & Pagonabarraga, J. (2009) · Movement Disorders · doi:10.1002/mds.22506 · Cited by 188
Rabinovici, G. D., Stephens, M. L., & Possin, K. L. (2015) · Continuum · doi:10.1212/01.con.0000466658.05156.54 · Cited by 163 · cited 1×
“However, executive dysfunction is not specific to PD and can be caused by a myriad of other factors such as sleep disturbance, medications, vascular disease, etc. [42].”
Biundo, R., Weis, L., Bostantjopoulou, S., Stefanova, E. D., Falup‐Pecurariu, C., Kramberger, M. G., Geurtsen, G. J., Antonini, A., Weintraub, D. A., & Aarsland, D. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1517-6 · Cited by 156 · cited 4×
“It has been suggested that MMSE is superior to MoCA in tracking change in PD [35], but other studies show no difference between the MMSE and MoCA in assessing change [20, 36, 37].”
InfluentialRosenthal, E. W., Brennan, L., Xie, S. X., Hurtig, H. I., Milber, J. M., Weintraub, D. A., Karlawish, J. H., & Siderowf, A. D. (2010) · Movement Disorders · doi:10.1002/mds.23073 · Cited by 153 · cited 1×
“There are both motor and cognitive components to disability in PD, however functionally relevant, practical cognitive assessments to detect this are limited [9, 10, 38].”
Cahn, D. A., Sullivan, E. V., Shear, P. K., Adolf Pfefferbaum, A., Heit, G., & Silverberg, G. D. (1998) · Archives of Clinical Neuropsychology · doi:10.1016/s0887-6177(98)00024-9 · Cited by 151
Lawson, R. A., Yarnall, A. J., Duncan, G. W., Khoo, T. K., Breen, D. P., Barker, R. A., Collerton, D., Taylor, J.-P., & Burn, D. J. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.07.004 · Cited by 148
Cognitive decline in Parkinson’s disease: the complex picture
Biundo, R., Weis, L., & Antonini, A. (2016) · npj Parkinson's Disease · doi:10.1038/npjparkd.2016.18 · Cited by 147 · cited 1×
“It has been suggested that MMSE is superior to MoCA in tracking change in PD [35], but other studies show no difference between the MMSE and MoCA in assessing change [20, 36, 37].”
Multicenter Validation of an MMSE ‐Mo CA Conversion Table
Bergeron, D., Flynn, K., Verret, L., Poulin, S., Bouchard, R. W., Bocti, C., Fülöp, T., Lacombe, G., Gauthier, S., Nasreddine, Z., et al. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14779 · Cited by 144 · cited 1×
“The higher cut-off (below 28) is the most accurate score identified in PD-specific populations to discriminate between cognitively normal and cognitively impaired PwP [28] and is the suggested conversion for a MoCA score of 26 [32].”
People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance
Burdick, D. J., Cholerton, B., Watson, G. S., Siderowf, A. D., Trojanowski, J. Q., Weintraub, D. A., Ritz, B. R., Rhodes, S. L., Rausch, R., Factor, S. A., et al. (2014) · Movement Disorders · doi:10.1002/mds.25924 · Cited by 109 · cited 2×
“More than half of persons with PD (PwP) who have normal MMSE scores are found to be impaired by other cognitive assessments [21, 22].”
Pirogovsky, E., Schiehser, D. M., Obtera, K. M., Burke, M. M., Lessig, S. L., Song, D. D., Litvan, I., & Filoteo, J. V. (2014) · Neuropsychology · doi:10.1037/neu0000045 · Cited by 99
Chou, K. L., Lenhart, A., Koeppe, R. A., & Bohnen, N. I. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.07.008 · Cited by 87
Quality improvement in neurology: Parkinson disease update quality measurement set
Factor, S. A., Bennett, A., Hohler, A. D., Wang, D., & Miyasaki, J. M. (2016) · Neurology · doi:10.1212/wnl.0000000000002670 · Cited by 87 · cited 1×
“The PD quality measures from the American Academy of Neurology recommend screening for cognitive impairment in PD at least annually [4].”
Changes on brief cognitive instruments over time in Parkinson's disease
Lessig, S. L., Nie, D., Xu, R., & Corey‐Bloom, J. (2012) · Movement Disorders · doi:10.1002/mds.25070 · Cited by 86
Risk factors for progression in Parkinson's disease
Goetz, C. G., Tanner, C. M., Stebbins, G. T., & Buchman, A. S. (1988) · Neurology · doi:10.1212/wnl.38.12.1841 · Cited by 78 · cited 1×
“Cognitive impairment is associated with more rapid progression of motor disability [39, 40] and advanced PD is associated with postural instability and falls [41], increased disability, and reduced quality of life [7–10].”
Espay, A. J., Guskey, M. T., Norton, J. C., Coate, B., Vizcarra, J. A., Ballard, C. G., Factor, S. A., Friedman, J. H., Lang, A. E., Larsen, N. J., et al. (2018) · Movement Disorders · doi:10.1002/mds.27488 · Cited by 58
Longitudinal study of the motor response to levodopa in Parkinson's disease
Clissold, B. G., McColl, C. D., Reardon, K. A., Shiff, M., & Kempster, P. A. (2006) · Movement Disorders · doi:10.1002/mds.21126 · Cited by 57 · cited 1×
“Cognitive impairment is associated with more rapid progression of motor disability [39, 40] and advanced PD is associated with postural instability and falls [41], increased disability, and reduced quality of life [7–10].”
Sawada, H., Oeda, T., Kohsaka, M., Umemura, A., Tomita, S., Park, K., Mizoguchi, K., Matsuo, H., Hasegawa, K., Fujimura, H., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318107 · Cited by 48
Faust‐Socher, A., Duff-Canning, S. J., Grabovsky, A., Armstrong, M. J., Rothberg, B., Eslinger, P. J., Meaney, C. A., Schneider, R. B., Tang‐Wai, D. F., Fox, S. H., et al. (2019) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000496454 · Cited by 37
Self-citationMild Cognitive Impairment in Parkinson’s Disease: Impact on Caregiver Outcomes
Szeto, J. Y. Y., Mowszowski, L., Gilat, M., Walton, C. C., Naismith, S. L., & Lewis, S. J. G. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160823 · Cited by 30
Choi, S., Yoon, G.-J., Jung, H.-J., & Kim, B. C. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03860-0 · Cited by 16
Cited by
Bao, X., Zheng, Z., Lv, J., Bao, J., Chang, S., Jiang, X. M., & Xin, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1265571 · Cited by 24
Zhao, X., Li, L., Ma, X., Li, Y., Gao, B., & Luo, W. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02704-8 · Cited by 12
“A score of < 26 indicates cognitive dysfunction (Allison et al. 2021).”
Cognitive impairment in Parkinson’s disease and other parkinsonian syndromes
Giannakis, A., Sioka, C., Kloufetou, E., & Konitsiotis, S. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02865-0 · Cited by 13
“Overall, while MMSE is a common screening tool for PD and APDs, its sensitivity for detecting their core deficits, such as executive, attention, and visuospatial, is limited (Snyder et al. 2021).”
Zheng, W., Pan, Y., Li, K., Tao, K., Wang, Q., & Yang, Y. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1418751 · Cited by 9
Amadiaz, Y., Alfonso-Lizarazo, E. H., & Moh, A. N. S. (2025) · Array · doi:10.1016/j.array.2025.100575 · Cited by 11
Metadata
- Authors
- Snyder, A., Gruber-Baldini, A. L., Rainer von Coelln, F., Savitt, J. M., Reich, S. G., Armstrong, M. J., & Shulman, L. M.
- Affiliations
- University of Maryland, Baltimore (US)
- Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA
- Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA
- University of Florida Health (US)
- Corresponding author
- Snyder, Allison
- Venue
- Journal of Parkinson's Disease
- Publisher
- SAGE Publications
- Published
- 2021-10-12
- Volume
- 11
- Issue
- 4
- Pages
- 1995-2003
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- OpenAlex
- W3187396869
- Cited by
- 20
- References
- 41
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 1
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Parkinson s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Social Sciences › Psychology › Clinical Psychology › Historical and Modern Theater Studies
- Keywords
- Parkinson's disease, cognitive impairment, Mini-Mental State Examination, Montreal Cognitive Assessment, cognitive screening, disease severity, disability, activities of daily living, Unified Parkinson's Disease Rating Scale, Hoehn and Yahr stage, early detection of cognitive impairment
- MeSH terms
- Mental Status and Dementia Tests, Activities of Daily Living, Humans, Neuropsychological Tests, Parkinson Disease, Severity of Illness Index, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.